Bryce Point Capital LLC Purchases Shares of 10,550 Ryan Specialty Holdings Inc. (NYSE:RYAN)

Bryce Point Capital LLC purchased a new stake in Ryan Specialty Holdings Inc. (NYSE:RYAN) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 10,550 shares of the company’s stock, valued at approximately $731,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in RYAN. Vanguard Group Inc. raised its stake in shares of Ryan Specialty by 5.7% in the fourth quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company’s stock worth $633,933,000 after purchasing an additional 529,631 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of Ryan Specialty by 2.5% in the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company’s stock worth $210,651,000 after purchasing an additional 79,976 shares during the last quarter. Principal Financial Group Inc. raised its stake in shares of Ryan Specialty by 66.4% in the first quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company’s stock worth $225,404,000 after purchasing an additional 1,218,147 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Ryan Specialty by 2.7% in the fourth quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company’s stock worth $115,468,000 after purchasing an additional 46,960 shares during the last quarter. Finally, Barclays PLC raised its stake in shares of Ryan Specialty by 3.0% in the fourth quarter. Barclays PLC now owns 1,690,279 shares of the company’s stock worth $108,449,000 after purchasing an additional 48,536 shares during the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Ryan Specialty Stock Up 2.8%

Shares of RYAN stock opened at $66.23 on Monday. The stock has a 50 day moving average of $67.31 and a 200 day moving average of $68.37. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 3.45. The stock has a market cap of $17.38 billion, a P/E ratio of 194.78, a P/E/G ratio of 1.79 and a beta of 0.66. Ryan Specialty Holdings Inc. has a twelve month low of $59.13 and a twelve month high of $77.16.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The company had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. During the same period last year, the company earned $0.35 earnings per share. Ryan Specialty’s quarterly revenue was up 25.0% compared to the same quarter last year. As a group, sell-side analysts expect that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.72%. The ex-dividend date of this dividend was Tuesday, May 13th. Ryan Specialty’s payout ratio is currently 141.18%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on RYAN. Wells Fargo & Company reduced their price objective on Ryan Specialty from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, July 10th. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating for the company in a research note on Wednesday, April 9th. Barclays reduced their price objective on Ryan Specialty from $83.00 to $79.00 and set an “overweight” rating for the company in a research note on Monday, July 7th. Wall Street Zen cut Ryan Specialty from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, Morgan Stanley reduced their price target on Ryan Specialty from $80.00 to $78.00 and set an “overweight” rating for the company in a research report on Monday, July 14th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $76.00.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,377 shares of the firm’s stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $65.84, for a total value of $946,581.68. Following the sale, the executive vice president directly owned 1,117 shares of the company’s stock, valued at approximately $73,543.28. This trade represents a 92.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David P. Bolger sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the sale, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. 52.21% of the stock is currently owned by company insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.